Compare Moody's Corporation (MCO) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moody's Corporation vs TransMedics Group Inc — how do they compare? Moody's Corporation trades at $490.77 (market cap $88.28B), while TransMedics Group Inc trades at $74.3 (market cap $2.54B). The key difference: Moody's Corporation is far larger — about 34.8× TransMedics Group Inc's market cap, and Moody's Corporation pays a 0.82% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| MCO | TMDX | |
|---|---|---|
Market Cap | $88.28B | $2.54B |
Sector | Financials | Technology |
52-Week High | $539.61 | $150.42 |
52-Week Low | $412.23 | $61.99 |
Enterprise Value | $94.08B | $2.94B |
Dividend Yield | 0.82% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moody's Corporation
Moody's, along with S&P Ratings, is a leading provider of credit ratings on fixed income securities. Moody's ratings segment, known as Moody's Investors Service or MIS, includes corporates, structured finance, financial institutions, and public finance ratings. MIS represents a majority of the firm's revenue and profits. Moody's other segment is Moody's Analytics and consists of Research, Data, and Analytics or RD&A and Enterprise Risk Solutions or ERS. RD&A's products include credit research, quantitative credit scores, economic research, business intelligence, know your customer (KYC) tools, commercial real estate data and analytical tools, and training services. ERS includes risk management software solutions to financial institutions.
Read more on MCO →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
